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Abstract: This paper presents a novel method for direct detection of Plasmodium falciparum 
histidine rich protein-2 (PfHRP-2) antigen using carbon nanofiber (CNF) forests grown on 
glass microballoons (NMBs). Secondary antibodies specific to PfHRP-2 densely attached 
to the CNFs exhibit extraordinary ability for the detection of minute concentrations of 
Plasmodium species. A sandwich immunoassay protocol was employed, where a glass 
substrate was used to immobilize primary antibodies at designated capture zones.   
High signal amplification was obtained in both colorimetric and electrical measurements 
due to the CNFs through specific binding. As a result, it was possible to detect PfHRP-2 
levels as low as 0.025 ng/mL concentration in phosphate buffered saline (PBS) using a 
visual signal within only 1 min of test duration. Lower limits of 0.01 ng/mL was obtained 
by measuring the electrical resistivity of the capture zone. This method is also highly 
selective and specific in identifying PfHRP-2 and other Plasmodium species from the same 
solution. In addition, the stability of the labeling mechanism eliminates the false signals 
generated by the use of dyes in current malaria rapid diagnostic test kits (MRDTs). Thus, 
the rapid, sensitive and high signal amplification capabilities of NMBs is a promising tool 
for early diagnosis of malaria and other infectious diseases. 
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1. Introduction 
Malaria is one of the most fatal infectious tropical diseases known to humans. Malaria has always 
been a medical emergency, especially, among children under 5 years old and pregnant women.   
The disease spreads mostly in places with limited resources such as in Sub-Saharan Africa, South 
America, and Asia [1–5]. These areas usually are also characterized by high temperature and humidity, 
coupled with environmental degradation. Delays in diagnosis and lack of effective treatment are 
leading causes of death in many malaria rife countries [6]. In addition, the development of resistance to 
treatments from repeated use of non-prescribed malaria drugs continues to pose challenges in 
management of the disease [7–11]. 
Approximately 300 to 500 million global cases of clinical malaria are reported yearly, with an 
estimated 627,000 deaths occurring in 2012 [12]. Of these deaths, children in Africa have been the 
most affected due to their vulnerability to infection as a result of malnutrition. Most of these deaths 
related to malaria can be prevented with prompt diagnosis and treatment [6]. The long-lasting 
experience of microscopy-based diagnostics in poor regions and settings turns it undoubtedly into a 
relatively simple technique, in the sense that, although still requiring trained manpower, the technique is 
widely known and available. The result of this is that microscopy may be more feasible and cost-effective 
where it has already been deployed. Moreover, microscopy is usually advantageous over malaria rapid 
diagnostic test kits (MRDTs) for identifying the actual infecting species (as different Plasmodium 
species imply different therapeutic options) and in the case of mixed infections. It is also especially 
important when a MRDT yields a negative result in a suspicious case and/or in endemic regions. So 
far, MRDTs have been the obvious preferred choice where microscopy is not available. 
The microscopy-based approach is able to detect as few as 5 parasites/µL of blood while MRDTs are 
only able to detect parasitemia above 100 parasites/µL [13]. In addition to low sensitivity, MRDTs lack 
specificity as a result of their inability to differentiate between individual Plasmodium species [14–18]. 
Plasmodium falciparum and Plasmodium vivax are the two most fatal malaria parasites. Histidine-rich 
protein II (HRP-2), genus-specific of Plasmodium species, is localized in several cell compartments 
including the cytoplasm of Plasmodium  falciparum [19]. Plasmodium falciparum histidine rich 
protein-2 (PfHRP-2) can also be detected in in vitro culture supernatants of synchronized parasites as 
early as 2 to 8 h after trophozoite development [20]. The trophozoites are the ring-like morphology of 
Plasmodium species observed in stained blood films. PfHRP-2 is recovered from culture supernatants 
as a secreted water soluble protein with large amount of the functional amino acid groups needed for 
subsequent biological interaction [21,22]. 
The key advantage of using MRDTs is the simplicity of signal detection and ease of result 
interpretation. They are also rapid and cost-effective. The increase use of MRDTs by a larger populace 
has led to the minimization of treatment based on symptoms [14,17]. However, MRDTs are mainly 
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leading to false readings [23]. MRDTs also often suffer from low signal intensity and poor quantitative 
discrimination of the color-formation reaction based on label accumulation [24]. Hence, the labeling 
mechanism is key for improved performance of MRDTs. Substitution of these dyes and enzymes with 
a material such as carbon nanofiber (CNF) forest grown on glass microballoons (NMBs) could provide 
enhanced signal identification. 
The NMBs are a combination of microballoons with millions of CNFs grown on their surface.  
The microballoons act as substrates and light weight transporters with the CNFs providing the large 
surface area and material properties needed for effective biomolecule immobilization. Overall, NMBs 
presents a new platform for the construction of immunoassays with many detection mechanisms. They 
can be used in electrochemical, optical, mass sensitive, colorimetric, and immunodipstick 
immunoassays for inherent signal amplification. The use of NMBs in immunoassays also provides the 
ability to multiplex and reduce background signal from biological samples and assay components, 
hence reducing background noise. NMBs can also act as modifiers of the electrotransducer surfaces, 
creating nanostructures with improved electrochemical response. The improvement in response may 
come either from the enhancement of the electron transfer or the increased efficiency of biomolecule 
immobilization [25]. 
This paper establishes the successful implementation of NMBs in rapid diagnostic test kits (RDTs) 
for diagnosis of malaria. The NMBs conjugated with rabbit polyclonal to PfHRP-2 antibody   
(Rb-PAbfs) were prepared and used to detect PfHRP-2 with standard solutions ranging from 0.01 to  
10 ng/mL. The following sections explain the details of the preparation of this immunosensor as well 
as the investigation of its performance and detection limit. Sensitivity and specificity of the method 
was evaluated by detecting PfHRP-2 from a solution of PfHRP-2 and Plasmodium vivax merozoites 
surface protein-1 (PvMSP-1) antigen. This NMBs immunoassay approach offers healthcare providers a 
simple, rapid, ultrasensitive and selective tool for the early management of malaria infections. 
2. Materials and Methods 
2.1. Reagents and Materials 
Plain S22 glass microballoons were purchased from 3M Corporation (St. Paul, MI, USA). The 
following chemicals were used for the study: polyethylene glycol solution (PEG, MW = 8000), 
glycerol, and bovine serum albumin (BSA) were purchased from Sigma-Aldrich (St. Louis, MO, 
USA); phosphate buffered saline 1× solution (PBS), 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide 
hydrochloride (EDC), and N-hydroxysulfosuccinimide (sulfo-NHS) obtained from Thermo Fisher 
Scientific (Waltham, MA, USA); Plasmodium falciparum histidine rich protein-2 (PfHRP-2) antigen, 
PvMSP-1, mouse monoclonal to PvMSP1 antibody (Ms-MAbv), rabbit polyclonal to PvMSP1 
antibody (Rb-PAbv), mouse monoclonal to PfHRP-2 antibody (Ms-MAbf), and Rb-PAbf were 
obtained from MyBioSource Inc. (San Diego, CA, USA). All biological samples were purchased in a 
PBS solution, pH 7.4, containing 0.1% sodium azide. 
Micro glass slides were obtained from Corning Inc. (Corning, NY, USA). Tween-20 purchased from 
Amresco (Solon, OH, USA), NaOH, H2SO4, and H2O2 from Macron Chemicals (Center Valley, PA, 
USA) were used for the cleaning process. Anhydrous toluene solution from Macron Chemicals, Sensors 2014, 14  14689 
 
 
glutaraldehyde obtained from Sigma-Aldrich (St. Louis, MO, USA), and 3-aminopropyl- triethoxysilane 
(APTES) from Alfa Aesar Chemicals (Ward Hill, MA, USA) were used in the amino functionalization 
of the glass slides. 
2.2. Fabrication of NMBs 
The surface of S22 glass microballoons were functionalized, activated and coated with Ni as 
described by Gao et al. [26]. CNFs were subsequently grown on the Ni-coated glass microballoons using 
a chemical vapor deposition (CVD) technique described in reference [27]. Surface functionalization of 
the CNFs on the NMBs was achieved by oxidizing the CNFs in air at 400 °C in a CVD furnace for an 
hour. The functionalization generates the carboxyl functional group onto the surface of the CNFs. 
The method used to organize the CNFs into well-defined spatial orientations on microsized spheres 
results in the growth of several millions of the CNFs on each microballoon [27]. The microsized 
structure of the NMBs greatly enhances the aggregation reaction necessary for obtaining visual signals. 
This aggregation of the NMBs at the capture zone drastically eliminates the wrong diagnoses currently 
encountered in RDTs. The high reactivity of NMBs with Plasmodium species will also allow low 
parasitemia to be detected. 
2.3. NMB-Plasmodium Species Conjugation 
CNFs have very high chemical affinity for biospecies [28]. A two-step reaction approach [29] was 
used in preparing the surface of CNFs for covalent conjugation with Rb-PAbf and Rb-PAbv.   
This reaction forms an ester intermediate on the NMBs that aids the amidation reaction. The amidation 
reaction involves the reaction of the intermediate with the primary amine group on the surfaces of  
Rb-PAbf. Same procedure was followed for the covalent conjugation of NMBs with Rb-PAbv.   
Very strong amide bonds were formed in each of the processes [29]. PEG was then applied forming a 
polyethylene oxide coating on NMBs. This coating prevents non-specific binding (NSB) of unwanted 
proteins to the NMBs. 
2.4. Preparation of the Glass Substrate 
Glass slides were cut into rectangular shapes (1 cm × 2.5 cm) and single capture zones marked 
within the mid portion of the slides. The slides were first cleaned using an ultrasonic bath in deionized 
water containing 2% Tween-20 by volume for an hour. The washed slides were then thoroughly 
flushed in deionized water and immersed in an ultrasonic bath again for an hour. 
Surface modification of glass with APTES reported by Tang et al. [30] and Tsutsumi et al. [31] was 
modified to suit our process. Slides were initially soaked in 1 M NaOH for 30 min and then rinsed with 
deionized water. Washed slides were soaked in piranha solution, 30% H2O2 and 70% H2SO4, at 80 °C 
for 2 h. They were thoroughly washed with deionized water, followed by ethanol and acetone and 
dried for an hour at 110 °C. The role of piranha solution was to roughen the surface of the slides for 
subsequent immobilization procedures. Modification by immersing slides in 5% APTES in anhydrous 
toluene solution for 10 min ensued immediately resulting in the formation of amino groups on the Sensors 2014, 14  14690 
 
 
surface of the glass slides. The slides were then thoroughly rinsed with toluene and acetone before 
drying at 110 °C for an hour. This process removed the excess APTES and toluene solution. 
Activation of the amino-functionalized slide surfaces was achieved by immersing the slides in a 3% 
glutaraldehyde in PBS solution for an hour. The slides were thoroughly rinsed with ethanol and 
deionized water to completely remove unreacted glutaraldehyde. Nitrogen gas was used to dry the 
slides. A solution made up of 50 µL of 1 mg/mL Ms-MAbf and 20 µL of glycerol was prepared and 
spotted on the capture zone of the slide. The slide was left to incubate for an hour after which it was 
thoroughly washed with PBS to remove Ms-MAbf. The slide was finally incubated in a 2% BSA and 
0.05% Tween-20 in PBS solution for an hour in order to block all sites from NSB. A plain glass slide 
was also incubated in the 2% BSA and 0.05% Tween-20 in PBS solution for an hour. This was used as 
a control for NSB. 
2.5. NMB-Polyclonal Antibody Conjugation 
Single and double capture zones were marked on several other slides. The slides were thoroughly 
cleaned, modified, and activated with amino functional groups as described earlier. All capture zones 
were treated to prevent non-specific binding. Firstly, Ms-MAbf were immobilized on several glass 
slides with single capture zone marks. The capture zone was used for sandwich immunoassay 
investigation of PfHRP-2 with concentrations in the linear range of 0.01 ng/mL and 10 ng/mL.   
The visual and electrochemical detection limits of the PfHRP-2 were determined within this range. 
Secondly, for the glass slides with double capture zones, Ms-MAbf were immobilized on the first 
capture zone and Ms-MAbv on the second capture zone. Same immunoassay procedure was then 
executed. For performance evaluation, PfHRP-2 was caught at the first capture zone. Experiment was 
repeated now using PvMSP-1 sample in PBS with concentrations ranging from 0.01 to 10 ng/mL. 
PvMSP-1 was caught at the second capture zone. 
Thirdly, solutions made up of equal amounts of PfHRP-2 and PvMSP-1 samples were also 
prepared. Concentrations in the range of 0.01 ng/mL and 10 ng/mL for both antigens in this assay 
confirmed that PfHRP-2 was caught at the first capture zone and PvMSP-1 at the second capture zone. 
This allows the identification of both antigens from the same mixed sample in a single assay. Scanning 
electron microscopy (SEM), optical microscopy, and electrical resistivity characterization were performed. 
2.6. Characterization 
A Pro-4 four point system (Lucas Labs, Gilroy, CA, USA) was used in resistivity measurements. The 
system was made up of a Keithley 2400, a Pro4, and a notebook with the Pro4 V1.2.4 software installed. 
The system uses the dual configuration test method of ASTM standard F84-99 to compensate for errors in 
probe spacing and errors caused by proximity to the edge of the conducting layer. A V/I measurement was 
taken and recorded and the subsequent resistivity was computed. 
Scanning electron microscope (SEM) micrographs were obtained using a Quanta 3D FEG Dual Beam 
FIB/SEM and its xT Microscope Control Software (FEI, Hillsboro, OR, USA). Fluorescence studies 
were performed on samples using a DM RXA2 fluorescence microscope (Leica, Wetzlar, Germany) 
fitted with a 100× objective lens with a 1.4 N.A. Slidebook version 4.1 was used for image acquisition 
from a SensiCam QE camera (Cooke, Auburn Hills, MI, USA) attached to the microscope. Sensors 2014, 14  14691 
 
 
Optical images were obtained from a 40 CFL inverted microscope (Axiovert, Thornwood, NY, 
USA) fitted with a 20× objective with a 1.0 N.A. AxioVision 4.6.1.0 was used for image acquisition 
from an AxioCam MRc camera attached to the microscope. Percentage area covered by the NMBs on 
the glass slides were determined using the ImageJ 1.46r software (Wayne Rasband, National Institutes 
of Health, USA). 
3. Results and Discussion 
3.1. Principle of Disease Diagnosis 
Most MRDTs currently employ the immunochromatographic strip assay technique. This technique 
allows for separation and identification of soluble antigens in solution using complementary antibodies. 
The technique allows for mass production of kits, which in turn allows lower manufacturing and 
distribution cost, and a simplified supply chain. The strip assay technique also allows for easy training 
of users, standardization of result interpretation, and ease of use in countries or regions where multiple 
languages are spoken [32]. 
Similarly, the NMBs detection technique is based on the immunochromatography sandwich 
approach. As a result of specific binding between the capture antibody and antigen, visible signal is 
generated from the NMBs conjugated with secondary antibody. The optical signal is assessed using the 
naked eye and quantified using a reading device. Immobilized NMBs on the capture zone can also be 
quantified using the change in electrical resistivity of that capture zone. 
The success of the sandwich immunoassay test requires the use of an antigen large enough to 
contain at least two epitopes [33]. PfHRP-2, which satisfies this requirement, has two epitopes specific 
to Ms-MAbf and Rb-PAbf. The primary monoclonal antibody, Ms-MAbf, was immobilized on the 
capture zone of the glass slide as shown in Figure 1a. PfHRP-2 in PBS was applied to the sample pad 
of the strip. Extra PBS was introduced and acts as a lysing agent to improve the sample flow to the 
absorption pad. The sample mixture migrated across the membrane to the capture zone, where   
Ms-MAbf immobilized on the strip surface captured most of the PfHRP-2 present in the mixture.  
The absorption pad regulated the flow and collected all excess fluid. A second liquid sample of 
secondary polyclonal antibodies, Rb-PAbf, coupled to NMBs in PBS is applied to the sample pad.  
The Rb-PAbf and NMBs conjugate bind to different epitopes on the captured PfHRP-2 antigens. As a 
result, the Rb-PAbf and NMBs conjugate captured by the PfHRP-2 generated a dark line at the capture 
zone, giving a positive test result as shown in Figure 1b. Electrical resistivity of the capture zone can 
also be obtained as shown in Figure 1b. 
3.2. Synthesis of NMBs 
SEM micrographs of the air-oxidized NMBs are shown in Figure 2. Several millions of the CNFs 
were uniformly grown on microballoons [27]. At higher magnifications, the CNFs were seen to have 
an average diameter of 50 nm and they were several micrometers in length. The oxidation process 
generated the carboxyl functional groups onto the surface of the CNFs. The CNFs forest with high 
aspect ratio and high chemical affinity offered several binding sites on which Rb-PAbf were 
immobilized. Due to the several millions of CNFs grown on each microballoon, the probability of Sensors 2014, 14  14692 
 
 
conjugating the Rb-PAbf on the NMBs is high. Large amounts of both amino and amine functional 
groups on the surface of Rb-PAbf permitted their covalent bonding with the carboxylated CNFs on the 
NMBs. This provided NMBs with ultra-low limit of detection for PfHRP-2. 
Figure 1. (a) Schematic illustration of the sandwich immunochromatographic set-up used to 
detect PfHRP-2 and (b) Illustration of the two different types of signal generation from the 
immunosensor. The yellow wire is used to show the connection for electrical measurement. 
(a) 
 
(b) 
Figure 2. SEM micrographs of air oxidized NMBs at different magnifications. 
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3.3. Detection Limit of PfHRP-2 Assay 
Successful immobilization of NMBs on the capture zone of the glass slide was achieved within one 
minute. NMBs were observed to form an interconnecting network at the capture zone as shown in Figure 3. 
This confirmed the detection of PfHRP-2 by the sandwich immunochromatography method. Increasing 
PfHRP-2 concentration increased the density of the immobilized NMB network at the capture zone. This 
is depicted in Figure 3a for the lowest visible PfHRP-2 concentration of 0.025 ng/mL and Figure 3b for 
the highest PfHRP-2 concentration studied. 
Figure 3. Optical micrographs depicting NMBs captured on glass slides in a sandwich 
assay format with (a) 0.025 ng/mL and (b) 10 ng/mL of PfHRP-2. 
A linear relationship between the percentage area covered by the NMBs (Apct) at the capture zone and 
the concentration of PfHRP-2 in the range of 0.01 to 10 ng/mL was attained (shown in Figure 4a). The 
correlation equation,      = 0.7212 + 1.286 	    = 0.9968  was used, where x is the concentration of 
PfHRP-2. This equation can be used to estimate the concentration of Plasmodium falciparum in any 
sample tested. The visual detection limit of the assay was 0.025 ng/mL. This is the lowest 
concentration at which the NMB network was observed with the unaided human eye. 
The lowest detection limit of PfHRP-2 reported in the literature to date using immunoassay 
technique has been 0.36 ng/mL [34]. The ultra-low visual detection limit of 0.025 ng/mL obtained 
from this study is attributed to the following. First, the high aspect ratio of CNFs makes available 
several binding sites for covalent bonding with Rb-PAbf. The high aspect ratio arises from the 
construction of the CNFs giving them length-to-diameter ratio of up to 132,000,000:1. This high ratio 
gives CNFs extensive area on their length for several of the nanosized antigens to be immobilized. 
Second, the exploitation of the high chemical reactivity of CNFs with antibodies of PfHRP-2 and 
organic surfactants make it possible for CNFs to be highly selective and specific in aqueous 
environment. Third, large effective surface area remains available on each micro-structured NMB 
allowing it to be treated with several millions of PfHRP-2 antibodies. Finally, the microstructure of the 
NMBs allows visual signal amplification and hence easier quantification. 
Signal detection and quantification of this immunosensor can also be achieved using electrical 
measurement. The high conducting nature of CNFs [27] provides the flexibility to perform resistivity 
changes on the capture zone of the immunosensor in addition to the visual characterization explained 
(a) (b)Sensors 2014, 14  14694 
 
 
earlier. The interconnected pathway formed by the immobilized NMBs at the capture zone allowed for 
an effective electron transfer to be established with the electrode. The resistivity of the capture zone was 
measured at different PfHRP-2 concentrations as shown in Figure 4b. The higher the concentration of 
PfHRP-2, the higher was the density of the immobilized NMBs and hence the more the CNFs available 
for conduction. Resistivity of the plain glass slide used for the study was 9.30 × 10
10 Ω·cm. Resistivity 
measurement was also conducted in NSB case and it was measured as 8.99 × 10
10 Ω·cm. Appreciable 
change/reduction in resistivity was only observed for concentrations of PfHRP-2 0.01 ng/mL and greater. 
This set a limit of detection of 0.01 ng/mL, which is considered very low. 
Figure 4. (a) Variation of percent area of the capture zone covered with NMBs against 
PfHRP-2 concentrations and (b) Variation of electrical resistivity of the capture zone with 
immobilized PfHRP-2 concentration. The error bars in both graphs are also shown. 
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3.4. Selectivity of the PfHRP-2 Detection Assay 
The selectivity of the proposed method was also established. In order to determine this capability, 
two capture zones were spotted on the immunosensor. On the first capture zone, primary antibodies 
specific to PfHRP-2 were immobilized. Antibodies specific to PfMSP-1 were immobilized on the 
second capture zone, using the method described earlier. Figure 5a shows the immunosensor for the 
detection of 10 ng/mL of PfHRP-2 in PBS solution. Quantification of the percent area covered by 
captured NMBs showed that increasing antigen concentration increases the amount of NMBs 
immobilized at the capture zone. During the tests with various concentrations of PfHRP-2, no signal 
was observed at the second capture zone. 
Figure 5. Glass slides showing (a) visual signal obtained at the first capture zone from the 
detection of PfHRP-2 in PBS; (b) signal observed at the second capture zone from the 
detection of PvMSP-1 in solution; and (c) signals obtained at the PfHRP-2 and PvMSP-1 
capture zones from a mixed PfHRP-2 and PvMSP-1 solution. 
 
The assays with varying concentration of PfMSP-1 in PBS showed a colored signal only at the 
second capture zone. Figure 5b shows the immunosensor for the detection of 10 ng/mL of PfMSP-1 in 
PBS solution. Figure 6 shows the results of optical and electrochemical detection of PfMSP-1 at the 
second capture zones, similarly to the study described in Figure 5 for PfHRP-2 at the first capture 
zone. The correlation equation was      = 0.6133 + 2.1059 	    = 0.9902 . This has a good 
correlation and can be used to estimate the concentration of Plasmodium vivax in any sample tested. 
The visual detection limit of the assay thus obtained was 0.025 ng/mL. The lowest detection limit of 
PfMSP-1 reported in the literature using immunoassay technique is 6.3 ng/mL [35]. The limit of 
detection using electrical measurements for the detection of PfMSP-1 was 0.02 ng/mL (Figure 6b). 
In another set of tests, a solution containing equal concentrations of PfHRP-2 and PfMSP-1 in PBS 
was prepared. The concentration of both antigens used for the study ranged from 0.025 to 10 ng/mL.  
In all the tests performed, NMBs were observed to be captured selectively on either capture zones. 
Figure 5c shows the immunosensor with specific NMBs at both capture zones. 
This study showed that the NMB approach is selective in detecting mixed Plasmodium falciparum 
and Plasmodium vivax malaria parasites in solution. Antibodies specific to both PfHRP-2 and PfMSP-1 
captured only the desired antigen at their designated capture zones. Signal quantification was obtained 
using both colorimetric and electrical methods both capture zones. 
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Figure 6. (a) Variation of percent area of the capture zone covered with NMBs against 
PfMSP-1 concentrations and (b) Variation of the resistivity of the capture zone with the 
concentration of immobilized PfMSP-1. The error bars in both graphs are also shown. 
4. Conclusions 
This work has demonstrated a highly sensitive method of detecting malaria parasites using NMBs 
as a label based on sandwich immunoassay protocol. Enhanced signal amplification was obtained by 
visual detection of 0.025 ng/mL of PfHRP-2 in PBS within 1 min of testing. The method was also able 
to selectively capture PfHRP-2 and PfMSP-1 at different capture zones on the same immunosensor. 
Quantification of results were achieved by measuring the change in resistivity across the capture zone. 
This NMBs based detection eliminates the limitations imposed by MRDTs. The simplicity, speed, 
specificity, and ultra-sensitivity of this approach make it a potentially powerful tool for prompt 
diagnosis of malaria and detection of other infectious diseases. 
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